<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Balzarini, J.</title>
    <link>http://repub.eur.nl/res/aut/10232/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture (Article)</title>
      <link>http://repub.eur.nl/res/pub/8564/</link>
      <pubDate>1994-01-01T00:00:00Z</pubDate>
      <description>The inhibitory effects of the 9-(2-phosphonylmethoxyethyl)adenine-related
          compounds (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)-adenine,
          (S)-9-(3-fluoro-2-phosphonylmethoxypropyl)adenine,
          (R)-9-(2-phosphonylmethoxypropyl)adenine,
          (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine, and
          (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine on human hepatitis B
          virus replication in the human hepatoma cell line HepG2 2.2.15 and duck
          hepatitis B virus infection in primary duck hepatocytes were investigated.
          (R)-9-(2-phosphonylmethoxypropyl-2,6-diaminopurine had the lowest 50%
          inhibitory concentrations against hepatitis B virus and duck hepatitis B
          virus, 0.22 and 0.06 microM, respectively, i.e., two- to fivefold lower
          concentrations than required for (R)-9-(2-phosphonylmethoxypropyl)adenine
          and 9-(2-phosphonylmethoxyethyl)adenine. All compounds were not toxic in
          vitro at a concentration of 100 microM.</description>
    </item>
  </channel>
</rss>